Form 4 for TXMD TherapeuticsMD, Inc.
Accepted 2021-08-12 00:00:00 ET · period of report 2021-08-10 · accession 0001387131-21-008437 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-08-12 | 2021-08-12 | TXMD | DArecca James | CFO | S - Sale+OE | $0.87 | -93.3K | 123.8K | -43% | -$81.2K |
| D | 2021-08-12 | 2021-08-10 | TXMD | DArecca James | CFO | M - OptEx | — | +217.2K | 217.2K | New | — |
| D | 2021-08-12 | 2021-08-10 | TXMD | DArecca James | CFO | M - OptEx | $0.00 | -217.2K | 434.3K | -33% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-08-12 | S | D | 93,337 | $0.87 | 123,830 | D | — | — | (F3) This transaction was executed in multiple trades at prices ranging from $0.87 to $0.88. The price reported in Column 4 reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. |
| 2 | Common | Common Stock | 2021-08-10 | M | A | 217,167 | — | 217,167 | D | — | — | (F1) On August 10, 2021, the reporting person received 217,167 shares of common stock of the issuer in settlement of restricted stock units (RSUs), which vested on June 18, 2021. |
| 3 | Derivative | Restricted Stock Units | 2021-08-10 | M | D | 217,167 | $0.00 | 434,333 | D | $0.00 · — to — | 217,167 Common Stock | (F1) On August 10, 2021, the reporting person received 217,167 shares of common stock of the issuer in settlement of restricted stock units (RSUs), which vested on June 18, 2021. (F4) Each RSU represents a contingent right to receive one share of issuer common stock upon settlement. (F5) The RSUs vest in three equal installments annually beginning June 1, 2021 (the one-year anniversary of the date of the reporting person's appointment as Chief Financial Officer), becoming fully vested on June 1, 2023. |